Cite
HARVARD Citation
Jänne, P. et al. (n.d.). LBA4 Preliminary safety and efficacy of adagrasib with pembrolizumab in treatment-naïve patients with advanced non-small cell lung cancer (NSCLC) harboring a KRASG12C mutation. Immuno-oncology technology. p. . [Online].